. Author manuscript; available in PMC: 2022 Jul 14.

Published in final edited form as: Semin Immunol. 2021 Jul 14;51:101470. doi: 10.1016/j.smim.2021.101470

Table 2.

List of recent DNA and viral vectored vaccine clinical trials

Immunogen	NCT Trial number	Other names	Phase	Adjuvant	Completion Date^*
Prime: Ad4-Env CN54, MVA-CN54, Boost: CN54 gp140	NCT03408262	Ad4HIV	1	With protein boost: MPLA	Feb 2020
p24CE1/2 DNA, p55^gag DNA	NCT03181789	HVTN119	1	IL-12 via DNA	Apr 2020
ChAdOx1.tHIVconsv1, MVA.tHIVconsv3, MVA.tHIVconsv4	NCT04586673	HIV-CORE0052	1		Oct 2021
Prime: Polyvalent DNA with subtype A/B/C/AE gp120 + Gag Boost: Tetravalent gp120 protein from subtypes A/B/C/AE	NCT03409276	HVTN124	1	With protein boost: GLA-SE	Nov 2020
ChAdOx1.HTI and MVA.HTI	NCT04563377	HIV-CORE0051	1/2a		Oct 2021
ChAdOx1.tHIVconsv1, MVA.tHIVconsv3, MVA.tHIVconsv4	NCT04553016	HIV-CORE006	1		Jun 2022
Prime: Ad4-Env145NFL or Ad4-Env150KN Protein boost: 4571 gp140 trimer	NCT03878121	19-I-0069	1	With protein boost: Alum	Apr 2024
HCMV vectors expressing Gag, Rev/Tat/Nef, Pol, Env	NCT04725877	VIR-1111–2001	1a		Dec 2024

Actual or predicted completion date